Identification of residues involved in homodimer formation located within a β-strand region of the N-terminus of a Yeast G protein-coupled receptor

Journal of Receptors and Signal Transduction

Volumn 32, Issue 2, 2012, Pages 65-75

  Uddin, M Seraj ^a   Kim, Heejung ^a   Deyo, Amanda ^a   Naider, Fred ^b,c   Becker, Jeffrey M ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Disulfide cross linking; G protein coupled receptor (GPCR); Ste2p; Substituted cysteine accessibility method (SCAM); Yeast

Indexed keywords

BETA GALACTOSIDASE; CYSTEINE; G PROTEIN COUPLED RECEPTOR; HOMODIMER;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; DIMERIZATION; DISULFIDE BOND; LIGAND BINDING; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; BINDING SITES; CYSTEINE; IMMUNOBLOTTING; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, MATING FACTOR; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION;

SACCHAROMYCES CEREVISIAE;

EID: 84863284785     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2011.647352     Document Type: Article

References (68)

1. Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature 2009, 459, 356-363.
2. Lundstrom K. An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs. Methods Mol Biol 2009, 552, 51-66.
3. Williams C, Hill SJ. GPCR signaling: understanding the pathway to successful drug discovery. Methods Mol Biol 2009, 552, 39-50.
4. De Amici M, Dallanoce C, Holzgrabe U, Tränkle C, Mohr K. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities. Med Res Rev 2010, 30, 463-549.
5. Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 2011, 10, 47-60.
6. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745. (Pubitemid 30650186)
7. Jaakola VP, Grifth MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC. The 2.6 Angstrom crystal structure of a human a2a adenosine receptor bound to an antagonist. Science 2008, 322, 1211-1217.
8. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330, 1066-1071.
9. Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, Shi L, Newman AH, Javitch JA, Cherezov V, Stevens RC. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 2010, 330, 1091-1095.
10. Warne T, Moukhametzianov R, Baker JG, Nehmé R, Edwards PC, Leslie AG, Schertler G F, Tate CG. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Nature 2011, 469, 241-244.
11. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler G F. Structure of a β1-adrenergic G-protein-coupled receptor. Nature 2008, 454, 486-491.
12. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Tian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 2007, 318, 1258-1265. (Pubitemid 350172884)
13. Ratnala VR, Kobilka B. Understanding the ligand-receptor-G protein ternary complex for GPCR drug discovery. Methods Mol Biol 2009, 552, 67-77.
14. Hauser M, Kaufman S, Lee BK, Naider F, Becker JM. The frst extracellular loop of the Saccharomyces cerevisiae G protein-coupled receptor Ste2p undergoes a conformational change upon ligand binding. J Biol Chem 2007, 282, 10387-10397. (Pubitemid 47093452)
15. Javitch JA, Shi L, Liapakis G. Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors. Meth Enzymol 2002, 343, 137-156. (Pubitemid 32954138)
16. Karlin A, Akabas MH. Substituted-cysteine accessibility method. Meth Enzymol 1998, 293, 123-145. (Pubitemid 29342485)
17. Marsh L. Substitutions in the hydrophobic core of the alpha-factor receptor of Saccharomyces cerevisiae permit response to Saccharomyces kluyveri α-factor and to antagonist. Mol Cell Biol 1992, 12, 3959-3966.
18. Umanah GK, Huang L, Ding FX, Arshava B, Farley AR, Link AJ, Naider F, Becker JM. Identifcation of residue-to-residue contact between a peptide ligand and its G protein-coupled receptor using periodate-mediated dihydroxyphenylalanine cross-linking and mass spectrometry. J Biol Chem 2010, 285, 39425-39436.
19. Son CD, Sargsyan H, Naider F, Becker JM. Identifcation of ligand binding regions of the Saccharomyces cerevisiae α-factor pheromone receptor by photoafnity cross-linking. Biochemistry 2004, 43, 13193-13203. (Pubitemid 39362788)
20. Turcatti G, Nemeth K, Edgerton MD, Meseth U, Talabot F, Peitsch M, Knowles J, Vogel H, Chollet A. Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fuorescent amino acids at specifc sites. J Biol Chem 1996, 271, 19991-19998. (Pubitemid 26281747)
21. Sherman F. Getting started with yeast. Meth Enzymol 1991, 194, 3-21.
22. Huang LY, Umanah G, Hauser M, Son C, Arshava B, Naider F, Becker JM. Unnatural amino acid replacement in a Yeast G protein-coupled receptor in its native environment. Biochemistry 2008, 47, 5638-5648. (Pubitemid 351705175)
23. Slauch JM, Mahan MJ, Mekalanos JJ. Measurement of transcriptional activity in pathogenic bacteria recovered directly from infected host tissue. Bio Techniques 1994, 16, 641-644. (Pubitemid 2067197)
24. Raths SK, Naider F, Becker JM. Peptide analogues compete with the binding of alpha-factor to its receptor in Saccharomyces cerevisiae. J Biol Chem 1988, 263, 17333-17341.
25. David NE, Gee M, Andersen B, Naider F, Torner J, Stevens RC. Expression and purifcation of the Saccharomyces cerevisiae α-factor receptor (Ste2p), a 7-transmembrane-segment G protein-coupled receptor. Faseb J 1997, 11(9), 2805.
26. Pinson B, Chevallier J, Urban-Grimal D. Only one of the charged amino acids located in membrane-spanning regions is important for the function of the Saccharomyces cerevisiae uracil permease. Biochem J 1999, 339 (Pt 1), 37-42. (Pubitemid 29179288)
27. Choi Y, Konopka JB. Accessibility of cysteine residues substituted into the cytoplasmic regions of the α-factor receptor identifes the intracellular residues that are available for G protein interaction. Biochemistry 2006, 45, 15310-15317. (Pubitemid 46032457)
28. Shi C, Kaminskyj S, Caldwell S, Loewen MC. A role for a complex between activated G protein-coupled receptors in yeast cellular mating. Proc Natl Acad Sci USA 2007, 104, 5395-5400. (Pubitemid 47175691)
29. Shi C, Kendall SC, Grote E, Kaminskyj S, Loewen MC. N-terminal residues of the yeast pheromone receptor, Ste2p, mediate mating events independently of G1-arrest signaling. J Cell Biochem 2009, 107, 630-638.
30. Akal-Strader A, Khare S, Xu D, Naider F, Becker JM. Residues in the frst extracellular loop of a G protein-coupled receptor play a role in signal transduction. J Biol Chem 2002, 277, 30581-30590. (Pubitemid 34970752)
31. Martin NP, Celic A, Dumont ME. Mutagenic mapping of helical structures in the transmembrane segments of the yeast α-factor receptor. J Mol Biol 2002, 317, 765-788. (Pubitemid 34722163)
32. Shah A, Marsh L. Role of Sst2 in modulating G protein-coupled receptor signaling. Biochem Biophys Res Commun 1996, 226, 242-246. (Pubitemid 26332193)
33. Kim H, Lee BK, Naider F, Becker JM. Identifcation of specifc transmembrane residues and ligand-induced interface changes involved in homo-dimer formation of a Yeast G protein-coupled receptor. Biochemistry 2009, 48, 10976-10987.
34. Stefan CJ, Overton MC, Blumer KJ. Mechanisms governing the activation and trafcking of Yeast G protein-coupled receptors. Mol Biol Cell 1998, 9, 885-899. (Pubitemid 28173641)
35. Lin JC, Duell K, Konopka JB. A microdomain formed by the extracellular ends of the transmembrane domains promotes activation of the G protein-coupled α-factor receptor. Mol Cell Biol 2004, 24, 2041-2051. (Pubitemid 38248943)
36. Overton MC, Blumer KJ. The extracellular N-terminal domain and transmembrane domains 1 and 2 mediate oligomerization of a Yeast G protein-coupled receptor. J Biol Chem 2002, 277, 41463-41472. (Pubitemid 35257448)
37. Reneke JE, Blumer KJ, Courchesne WE, Torner J. The carboxy-terminal segment of the yeast α-factor receptor is a regulatory domain. Cell 1988, 55, 221-234.
38. Yesilaltay A, Jenness DD. Homo-oligomeric complexes of the yeast α-factor pheromone receptor are functional units of endocytosis. Mol Biol Cell 2000, 11, 2873-2884. (Pubitemid 32107071)
39. Li JH, Hamdan FF, Kim SK, Jacobson KA, Zhang X, Han SJ, Wess J. Ligand-specifc changes in M3 muscarinic acetylcholine receptor structure detected by a disulfde scanning strategy. Biochemistry 2008, 47, 2776-2788. (Pubitemid 351328828)
40. Li JH, Han SJ, Hamdan FF, Kim SK, Jacobson KA, Bloodworth LM, Zhang X, Wess J. Distinct structural changes in a G protein-coupled receptor caused by diferent classes of agonist ligands. J Biol Chem 2007, 282, 26284-26293. (Pubitemid 47443813)
41. Ward SD, Hamdan FF, Bloodworth LM, Siddiqui NA, Li JH, Wess J. Use of an in situ disulfde cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor. Biochemistry 2006, 45, 676-685. (Pubitemid 43122233)
42. Yu H, Kono M, McKee TD, Oprian DD. A general method for mapping tertiary contacts between amino acid residues in membrane-embedded proteins. Biochemistry 1995, 34, 14963-14969.
43. Yu H, Kono M, Oprian DD. State-dependent disulfde cross-linking in rhodopsin. Biochemistry 1999, 38, 12028-12032.
44. Guo W, Shi L, Filizola M, Weinstein H, Javitch JA. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci USA 2005, 102, 17495-17500. (Pubitemid 41740894)
45. Mancia F, Assur Z, Herman AG, Siegel R, Hendrickson WA. Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor. EMBO Rep 2008, 9, 363-369.
46. Eilers M, Hornak V, Smith SO, Konopka JB. Comparison of class A and D G protein-coupled receptors: common features in structure and activation. Biochemistry 2005, 44, 8959-8975. (Pubitemid 40943213)
47. Karnik SS, Gogonea C, Patil S, Saad Y, Takezako T. Activation of G-protein-coupled receptors: a common molecular mechanism. Trends Endocrinol Metab 2003, 14, 431-437. (Pubitemid 37392216)
48. Naider F, Becker JM. The α-factor mating pheromone of Saccharomyces cerevisiae: a model for studying the interaction of peptide hormones and G protein-coupled receptors. Peptides 2004, 25, 1441-1463. (Pubitemid 39221527)
49. Celic A, Connelly SM, Martin NP, Dumont ME. Intensive mutational analysis of G protein-coupled receptors in yeast. Methods Mol Biol 2004, 237, 105-120.
50. Dohlman HG, Torner J, Caron MG, Lefkowitz RJ. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 1991, 60, 653-688.
51. Ho HH, Du D, Gershengorn MC. The N terminus of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor is necessary for high afnity chemokine binding but not for constitutive activity. J Biol Chem 1999, 274, 31327-31332.
52. Hawtin SR, Wesley VJ, Parslow RA, Simms J, Miles A, McEwan K, Wheatley M. A single residue (arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists. Mol Endocrinol 2002, 16, 600-609. (Pubitemid 34214578)
53. Hagemann IS, Narzinski KD, Floyd DH, Baranski TJ. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking. J Biol Chem 2006, 281, 36783-36792. (Pubitemid 46042146)
54. Gurevich VV, Gurevich EV. How and why do GPCRs dimerize? Trends Pharmacol Sci 2008, 29, 234-240.
55. Dong C, Wu G. Regulation of anterograde transport of a2-adrenergic receptors by the N termini at multiple intracellular compartments. J Biol Chem 2006, 281, 38543-38554. (Pubitemid 46041979)
56. Mentesana PE, Konopka JB. Mutational analysis of the role of N-glycosylation in alpha-factor receptor function. Biochemistry 2001, 40, 9685-9694. (Pubitemid 32757908)
57. Akabas MH, Staufer DA, Xu M, Karlin A. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 1992, 258, 307-310.
58. Javitch JA. Probing structure of neurotransmitter transporters by substituted-cysteine accessibility method. Meth Enzymol 1998, 296, 331-346. (Pubitemid 28455031)
59. Mueckler M, Makepeace C. Analysis of transmembrane segment 8 of the GLUT1 glucose transporter by cysteine-scanning mutagenesis and substituted cysteine accessibility. J Biol Chem 2004, 279, 10494-10499. (Pubitemid 38372659)
60. Staufer DA, Karlin A. Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. Biochemistry 1994, 33, 6840-6849. (Pubitemid 24190807)
61. Prévost M, Vertongen P, Raussens V, Roberts DJ, Cnudde J, Perret J, Waelbroeck M. Mutational and cysteine scanning analysis of the glucagon receptor N-terminal domain. J Biol Chem 2010, 285, 30951-30958.
62. Lemaire K, Van de Velde S, Van Dijck P, Tevelein JM. Glucose and sucrose act as agonist and mannose as antagonist ligands of the G protein-coupled receptor Gpr1 in the yeast Saccharomyces cerevisiae. Mol Cell 2004, 16, 293-299. (Pubitemid 39388843)
63. Chen S, Lin F, Xu M, Graham RM. Phe(303) in TMVI of the alpha(1B)-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation. Biochemistry 2002, 41, 588-596. (Pubitemid 34062029)
64. Xu W, Li J, Chen C, Huang P, Weinstein H, Javitch JA, Shi L, de Riel JK, Liu-Chen LY. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of\i, 8, and K opioid receptors. Biochemistry 2001, 40, 8018-8029. (Pubitemid 32641199)
65. Sen M, Marsh L. Noncontiguous domains of the a-factor receptor of yeasts confer ligand specifcity. J Biol Chem 1994, 269, 968-973.
66. Wang HX, Konopka JB. Identifcation of amino acids at two dimer interface regions of the a-factor receptor (Ste2). Biochemistry 2009, 48, 7132-7139.
67. Falke JJ, Dernburg AF, Sternberg DA, Zalkin N, Milligan DL, Koshland DE Jr. Structure of a bacterial sensory receptor. A site-directed sulfhydryl study. J Biol Chem 1988, 263, 14850-14858.
68. Srinivasan N, Sowdhamini R, Ramakrishnan C, Balaram P. Conformations of disulfde bridges in proteins. Int J Pept Protein Res 1990, 36(2), 147-155.